2025-09-15T18:07:39+08:002024-11-20|
Contact Information
Title
Professor
Office
(Address) E12-2060 / (Phone) +853 8822 8031
Lab
(Address) E12-2047, 2049
Team Office
(Address) E12-2047, 2049
Email
jianguangji@um.edu.mo
Consultation Hours

Mon, Tue 10:00 – 11:00

Teaching

HSCI8203 Environmental Health Science

HSCI8204 Public Healthy Policy and Assessment

HSCI4006 Public Health 

Research Team
Name Position Office Phone Email
Di LIUPost-doctoral Fellow
Di LIUPost-doctoral FellowE12-2049+853 8822 2948liudi@um.edu.mo
Wen SUNResearch Assistant
Chak CHEONGPhD Studentyc57679@um.edu.mo
Chak CHEONGPhD Studentyc57679@um.edu.mo
Dongxue WANGPhD Student
Lin SUIPhD Studentyc58616@um.edu.mo
Lin SUIPhD Studentyc58616@um.edu.mo
Minshan LUPhD Studentyc57605@um.edu.mo
Minshan LUPhD Studentyc57605@um.edu.mo
Xinan SONGPhD Studentyc58607@um.edu.mo
Xinan SONGPhD Studentyc58607@um.edu.mo
Xuan YINPhD Studentyc57637@um.edu.mo
Xuan YINPhD Studentyc57637@um.edu.mo
Yunzhe CHENPhD Studentyc57662@um.edu.mo
Yunzhe CHENPhD Studentyc57662@um.edu.mo
Education
PhD Heidelberg University, Germany, 2009
MMed Chinese Academy of Preventive Medicine, China, 2000
BM Zhangjiakou Medical College, China, 1997
Position
2024 – Present Professor, Faculty of Health Sciences, University of Macau
2019 – 2024 Tenured Associate Professor, Center for Primary Health Care Research, Clinical Research Center, Lund University
2013 – 2019 Associate Professor, Center for Primary Health Care Research, Lund University
2009 – 2012 Senior Researcher, Center for Primary Health Care Research, Lund University
2006 – 2008 Assistant Researcher, Center for Family Medicine, Karolinska Institute
2004 – 2005 Assistant Researcher, Department of Bioscience, Karolinska Institute
Research Interests
Identify druggable targets for cancers and other common chronic diseases, including diabetes and cardiovascular diseases.

Provide evidence-based clinical guidance to advance precision medicine practices.

Investigate environmental and genetic factors contributing to the development of common cancers and chronic diseases, such as diabetes and cardiovascular diseases.
Representative Publications
  1. Yi H, Zheng X, Ji J: Levonorgestrel-releasing intrauterine device use and risk of gynecologic and breast cancers: the need for further evidence. Am J Obstet Gynecol 2025.
  2. Yi H, Zhang N, Sundquist J, Sundquist K, Zheng X, Ji J: Long-term outcomes after unilateral salpingo-oophorectomy: A registry-based retrospective cohort study. PLoS Med 2025, 22(7):e1004639.
  3. Wang D, Ji J: Timing matters in diagnosis of cancer with immune-mediated inflammatory disease. Nat Rev Rheumatol 2025.
  4. Liu Y, Sundquist J, Sundquist K, Ji J: Exploring the Influence of Parental Mental Illness on Childhood Cancer Mortality: A Nationwide Cohort Study in Sweden. J Natl Compr Canc Netw 2025:1-7.
  5. Zheng G, Chattopadhyay S, Sundquist J, Sundquist K, Ji J. Antihypertensive drug targets and breast cancer risk: A two-sample mendelian randomization study. European Journal of Epidemiology. 2024;39(5):535-548.
  6. Yi H, Zhang N, Huang J, Zheng Y, Hong QH, Sundquist J, Sundquist K, Zheng X, Ji J. Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: A national cohort study in sweden. American Journal of Obstetrics and Gynecology. 2024;231(4):450 e1-450 e12.
  7. Yi H, Ji J. Uncovering causal clues in the development of second primary cancers. Lancet Oncology. 2024;25(3):e97.
  8. Liu Y, Jiang Z, Sundquist J, Sundquist K, Ji J. Long-term pattern of psychotropic medication uses among swedish parents of children diagnosed with cancer. J Natl Compr Canc Netw. 2024;22(9)
  9. Zheng D, Li N, Hou R, Zhang X, Wu L, Sundquist J, Sundquist K, Ji J. Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: Nationwide cohort and mendelian randomization studies. BMC Medicine. 2023;21(1):40.
  10. Zhang N, Li Y, Sundquist J, Sundquist K, Ji J. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses. EBioMedicine. 2023;98:104859.
  11. Liu Y, Sundquist J, Sundquist K, Zheng D, Ji J. Mental health outcomes in parents of children with a cancer diagnosis in sweden: A nationwide cohort study. EClinicalMedicine. 2023;55:101734.
  12. Zhang N, Sundquist J, Sundquist K, Ji J. Proguanil and atovaquone use is associated with lower colorectal cancer risk: A nationwide cohort study. BMC Medicine. 2022;20(1):439.
  13. Huang W, Sundquist K, Sundquist J, Ji J. Use of dipyridamole is associated with lower risk of lymphoid neoplasms: A propensity score-matched cohort study. British Journal of Haematology. 2022;196(3):690-699.
  14. Hu LP, Huang W, Wang X, Xu C, Qin WT, Li D, Tian G, Li Q, Zhou Y, Chen S, et al. Terbinafine prevents colorectal cancer growth by inducing dntp starvation and reducing immune suppression. Molecular Therapy. 2022;30(10):3284-3299.
  15. Zheng G, Sundquist J, Sundquist K, Ji J. Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients. British Journal of Cancer. 2021;124(2):506-512.
  16. Zhang N, Sundquist J, Sundquist K, Zhang ZG, Ji J. Combined use of aspirin and selective serotonin reuptake inhibitors is associated with lower risk of colorectal cancer: A nested case-control study. American Journal of Gastroenterology. 2021;116(6):1313-1321.
  17. Huang W, Xiao J, Ji J, Chen L. Association of lipid-lowering drugs with covid-19 outcomes from a mendelian randomization study. Elife. 2021;10
  18. Huang W, Sundquist J, Sundquist K, Ji J. Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer. Nat Commun. 2020;11(1):3191.
  19. Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J. Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence. Seminars in Cancer Biology. 2020;64:114-121.
  20. Huang W, Sundquist J, Sundquist K, Ji J. Use of phosphodiesterase 5 inhibitors is associated with lower risk of colorectal cancer in men with benign colorectal neoplasms. Gastroenterology. 2019;157(3):672-681 e4.
  21. Ji J, Sundquist J, Sundquist K. Cholera vaccine use is associated with a reduced risk of death in patients with colorectal cancer: A population-based study. Gastroenterology. 2018;154(1):86-92 e1.
  22. Ji J, Sundquist J, Sundquist K. Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients. Nat Commun. 2018;9(1):2367.
  23. Ji J, Chen T, Sundquist J, Sundquist K. Type 1 diabetes in parents and risk of attention deficit/hyperactivity disorder in offspring: A population-based study in sweden. Diabetes Care. 2018;41(4):770-774.
  24. Ji J, Sundquist J, Sundquist K. Gender-specific incidence of autoimmune diseases from national registers. Journal of Autoimmunity. 2016;69:102-6.
  25. Ji J, Sundquist J, Sundquist K. Incidence and familial risk of pleural mesothelioma in sweden: A national cohort study. European Respiratory Journal. 2016;48(3):873-9.
  26. Ji J, Sundquist J, Sundquist K. Tonsillectomy associated with an increased risk of autoimmune diseases: A national cohort study. Journal of Autoimmunity. 2016;72:1-7.
  27. Kendler KS, Ji J, Edwards AC, Ohlsson H, Sundquist J, Sundquist K. An extended swedish national adoption study of alcohol use disorder. JAMA Psychiatry. 2015;72(3):211-8.
  28. Sundquist J, Sundquist K, Ji J. Autism and attention-deficit/hyperactivity disorder among individuals with a family history of alcohol use disorders. Elife. 2014;3:e02917.
  29. Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X. Incidence of cancer in patients with schizophrenia and their first-degree relatives: A population-based study in sweden. Schizophrenia Bulletin. 2013;39(3):527-36.
  30. Ji J, Zoller B, Sundquist K, Sundquist J. Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation. 2012;125(14):1742-7.
Full publications list
Awards
2007 Chinese Government Award for Outstanding Students Abroad
Research Grants
2024 – 2025 PI, MAS Cancer: Drug Repurposing for Colorectal Cancer Prevention and Treatment
2022 – 2024 PI, Vetenskapsrådet: Socioeconomic Consequences and Mental Health Outcomes in Parents and Siblings of Childhood Cancer Survivors
2022 – 2023 PI, MAS Cancer: Systematic Assessment of Drug Repurposing for Colorectal Cancer Prevention and Treatmen
2021 – 2022 PI, MAS Cancer: Systematic Assessment of Drug Repurposing for Colorectal Cancer Prevention and Treatment
2020 – 2021 PI, MAS Cancer: Drug Repurposing in Oncology using Swedish Register
2019 – 2020 PI, Crafoordska Stiftelsen: Systematic Assessment of Drug Repurposing in Oncolog
2018 – 2020 PI, Cancerfonden: National study of well-being in offspring of cancer survivor
2018 – 2019 PI, Crafoordska Stiftelsen: Systematic Assessment of Drug Repurposing in Oncology
2016 – 2017 PI, Crafoordska Stiftelsen: National study of adverse health outcomes in the offspring of cancer survivor
2017 – 2019 PI, Vetenskapsrådet: Nationell studie om hälsorisker hos barn till canceröverlevare
2017 – 2018 PI, Crafoordska Stiftelsen: National study of adverse health outcomes in the offspring of cancer survivor
2013 – 2015 PI, ALF: The genetic and environmental epidemiology of alcohol use disorders
2013 – 2015 PI, ALF: Epidemiological study of alcohol use disorders
2016 – 2018 PI, Fredrik och Ingrid Thurings Stiftelse: Alcohol use disorder in parents and mental disorder3 in offspring
Professional Activities
Associate editor in BMC Medicine